Review article · 2025 · Open access

Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects

Mingxuan Zheng, Jiale Chen, Hong Yang

Frontiers in Immunology, 16, 1658867 · Published 20 November 2025 · DOI 10.3389/fimmu.2025.1658867

Open PDFView at the publisherCite this paper

In brief

“Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects” is a 2025 review article by Mingxuan Zheng and 2 co-authors, published in Frontiers in Immunology. OpenAlex counts 1 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.09
References
149
Authors
3

Abstract

Autoimmune diseases (AID) comprise a diverse group of disorders driven by aberrant B-cell and T-cell reactivity against self-tissues. In recent years, cell-based therapies utilizing engineered T cells have emerged as a promising therapeutic strategy for AIDs. Notably, chimeric antigen receptor (CAR)-T cells have demonstrated the ability to selectively target and eliminate autoreactive immune populations, including pathogenic B cells and antibody-producing plasma cells. Beyond T-cell modulation, macrophages (MΦs) exhibit remarkable plasticity, differentiating into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes in response to microenvironmental cues. Advances in genetic engineering have enabled the development of CAR-MΦs (CAR-M), which hold potential for adoptive immunotherapy in certain diseases. However, CAR-M therapy remains experimental and requires further clinical validation. This review systematically evaluates the therapeutic potential of CAR-T and CAR-M in AIDs, comparing their respective advantages and limitations to provide a comprehensive foundation for future translational applications.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zheng, M., Chen, J., & Yang, H. (2025). Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects. Frontiers in Immunology, 16, 1658867. https://doi.org/10.3389/fimmu.2025.1658867

MLA 9

Zheng, Mingxuan, et al. “Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects.” Frontiers in Immunology, vol. 16, 2025, p. 1658867. https://doi.org/10.3389/fimmu.2025.1658867.

Chicago

Zheng, Mingxuan, Jiale Chen, and Hong Yang. 2025. “Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects.” Frontiers in Immunology 16: 1658867. https://doi.org/10.3389/fimmu.2025.1658867.

Harvard

Zheng, M., Chen, J. and Yang, H. (2025) ‘Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects’, Frontiers in Immunology, 16, p. 1658867. doi:10.3389/fimmu.2025.1658867.

IEEE

M. Zheng, J. Chen, and H. Yang, “Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects,” Frontiers in Immunology, vol. 16, p. 1658867, 2025, doi: 10.3389/fimmu.2025.1658867.

BibTeX

@article{zheng2025engineered,
  title     = {{Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects}},
  author    = {Zheng, Mingxuan and Chen, Jiale and Yang, Hong},
  journal   = {Frontiers in Immunology},
  year      = {2025},
  volume    = {16},
  pages     = {1658867},
  doi       = {10.3389/fimmu.2025.1658867},
  url       = {https://doi.org/10.3389/fimmu.2025.1658867}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • autoimmune disease
  • chimeric antigen receptor T cells
  • CAR macrophages
  • engineered T cells
  • adoptive immunotherapy
  • autoreactive B cells
  • plasma cells
  • macrophage polarization

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Zheng, M., Chen, J., & Yang, H. (2025). Engineered cell therapies for autoimmune diseases: evaluating CAR-T and CAR-M progress and prospects. Frontiers in Immunology, 16, 1658867. https://doi.org/10.3389/fimmu.2025.1658867

How many times has this paper been cited?

1 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Immunology: sign in and open the PDF from this page.

Who wrote this paper?

Mingxuan Zheng, Jiale Chen, Hong Yang.

What is the DOI of this paper?

10.3389/fimmu.2025.1658867, permanently at https://doi.org/10.3389/fimmu.2025.1658867. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.